Commission Delegated Regulation (EU) 2022/256 of 22 February 2022 amending Regulation (EU) 2021/953 of the European Parliament and of the Council as regards the issuance of certificates of recovery based on rapid antigen tests
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD) Area (EEA Agreement)
VIII Right of Establishment
Joint committee decision (JCD)
072/2022 In force in the EEA
Yes Legal documents
Commission Delegated Regulation (EU) 2022/256 of 22 February 2022 amending Regulation (EU) 2021/953 of the European Parliament and of the Council as regards the issuance of certificates of recovery based on rapid antigen tests
Framseld reglugerð framkvæmdastjórnarinnar (ESB) 2022/256 frá 22. febrúar 2022 um breytingu á reglugerð Evrópuþingsins og ráðsins (ESB) 2021/953 að því er varðar útgáfu vottorða um bata á grundvelli mótefnavakahraðprófa
Delegierte Verordnung (EU) 2022/256 der Kommission vom 22. Februar 2022 zur Änderung der Verordnung (EU) 2021/953 des Europäischen Parlaments und des Rates in Bezug auf die Ausstellung von Genesungszertifikaten auf der Grundlage von Antigen-Schnelltests
History
19.03.2022
Adopted JCD confirmed entry into force date
19.03.2022
Compliance date in the EEA
18.03.2022
Adoption of Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement
01.03.2022
Draft Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement sent to Commission
22.02.2022
Adoption date in the EU
24.02.2022
Compliance date in the EU
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.